Predictive markers of immune checkpoint blockade are identified in 13% of the ICC tumors, and the most commonly found is programmed cell death ligand 1 (PD-L1) overexpression, seen in 8%. The gene discussed is CD274; the disease is intrahepatic cholangiocarcinoma.